About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

47. Buerger disease Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 14 / Drugs : 18 - (DrugBank : 13) / Drug target genes : 7 - Drug target pathways : 19

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
   Cell Biopeutics Resources Sdn Bhd
      2024   Phase 4   NCT05854615   Malaysia
Allogeneic mesenchymal stem cells
   Stempeutics Research Pvt Ltd
      2012   Phase 2   NCT01484574   India
Basic fibroblast growth factor
   Kyoto University Graduate School of Medicine Department of Cardiovascular Surgery
      2009   -   JPRN-UMIN000002671   Japan
Bosentan
   Hospital Universitario Getafe
      2009   -   NCT01447550   Spain
Botox injection
   University Hospital, Toulouse
      2025   Phase 3   NCT05698979   -
Botulinum toxin type A
   CHU de Toulouse
      2022   Phase 4   EUCTR2021-005723-20-FR   France
CLBS12
   EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)
      2017   -   JPRN-jRCT1080223694   Japan
   Lisata Therapeutics, Inc.
      2017   Phase 2   NCT02501018   Japan
Erythropoietin
   EVEETA Study Group
      2016   -   JPRN-UMIN000021374   Japan
Filgrastim
   Kenichi Yamahara
      2024   Phase 1   JPRN-jRCT2052230115   -
G-CSF
   Kenichi Yamahara
      2024   Phase 1   JPRN-jRCT2052230115   -
   Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Research and Innovation (IBRI)
      2011   -   JPRN-UMIN000005227   Japan
Gelatin
   Kyoto University Graduate School of Medicine Department of Cardiovascular Surgery
      2009   -   JPRN-UMIN000002671   Japan
   The University of Tokyo Hospital
      2004   -   JPRN-C000000200   Japan
Ginkgo biloba
   First Clinical Center of Chinese PLA General Hospital
      2021   Phase 0   ChiCTR2100048104   China
Heparin
   First Clinical Center of Chinese PLA General Hospital
      2021   Phase 0   ChiCTR2100048104   China
Platelet rich plasma
   EVEETA Study Group
      2016   -   JPRN-UMIN000021374   Japan
Selexipag
   Actelion
      2021   -   NCT04914247   -
SOC
   Lisata Therapeutics, Inc.
      2017   Phase 2   NCT02501018   Japan
Thrombopoietin
   EVEETA Study Group
      2016   -   JPRN-UMIN000021374   Japan
Trafermin
   The University of Tokyo Hospital
      2004   -   JPRN-C000000200   Japan